Emergent BioSolutions Inc.
0IGA.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$366.42M
Close$
Share Statistics
| Market cap | $366.42 Million |
|---|---|
| Enterprise Value | $823.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.98 |
| Beta | 2.36 |
| Outstanding Shares | 51,600,000 |
Return
| Return on Equity | -53.78% |
|---|---|
| Return on Assets | -16.44% |
| Return on Invested Capital | -3.05% |
Valuation & Multiples
| P/E Ratio | -2.05 |
|---|---|
| PEG | -0.15 |
| Price to Sales | 0.49 |
| Price to Book Ratio | 1.15 |
| Enterprise Value to Revenue | 1.07 |
| Enterprise Value to EBIT | -27.18 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 1.75 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$177.50 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
$123.22 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Emergent Biosolutions Inc
900 employees
CEO: Robert Kramer Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unfo...